510(k) DEN200031

BioFire Respiratory Panel 2.1 (RP2.1) by Biofire Diagnostics, LLC — Product Code QOF

DEN200031 is an FDA 510(k) premarket notification submitted by Biofire Diagnostics, LLC for the device "BioFire Respiratory Panel 2.1 (RP2.1)". The FDA issued a decision of De Novo granted on Mar 17, 2021. The device falls under product code QOF (Multi-Target Respiratory Specimen Nucleic Acid Test Including Sars-Cov-2 And Other Microbial Agents), a Class II device regulated under 21 CFR 866.3981. Biofire Diagnostics, LLC has 37 other 510(k) clearances on record.

Clearance details

Decision
DENG (De Novo granted)
Decision Date
Mar 17, 2021
Date Received
May 19, 2020
Clearance Type
Direct
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Multi-Target Respiratory Specimen Nucleic Acid Test Including Sars-Cov-2 And Other Microbial Agents
Device Class
Class II
Regulation Number
866.3981
Review Panel
MI
Submission Type
510(k)

A device to detect and identify nucleic acid targets in respiratory specimens from microbial agents that cause the SARS-CoV-2 respiratory infection and other microbial agents when in a multi-target test is an in vitro diagnostic device intended for the detection and identification of SARS-CoV-2 and other microbial agents when in a multi-target test in human clinical respiratory specimens from patients suspected of respiratory infection who are at risk for exposure or who may have been exposed to these agents. The device is intended to aid in the diagnosis of respiratory infection in conjunction with other clinical, epidemiologic, and laboratory data or other risk factors.

Need the full FDA record for Biofire Diagnostics, LLC? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for DEN200031. Report a data issue: hello@regdatalab.com.